STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE(SR-AGVHD)
Clinical trials for STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE(SR-AGVHD) explained in plain language.
Never miss a new study
Get alerted when new STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE(SR-AGVHD) trials appear
Sign up with your email to follow new studies for STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE(SR-AGVHD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Lab-Grown cells offer hope for transplant complication
Disease control Recruiting nowThis study tests a new treatment made from special stem cells (iMSC) for people with a serious complication after bone marrow transplant called graft-versus-host disease that does not respond to steroids. The treatment aims to control the disease by calming the immune system. Abo…
Matched conditions: STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE(SR-AGVHD)
Phase: NA • Sponsor: Anhui Provincial Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Desperate patients get early access to promising drug
Disease control AVAILABLEThis program provides early access to the drug ruxolitinib for people with serious or life-threatening conditions like certain blood cancers, severe COVID-19, or graft-versus-host disease. It is for patients who have no other treatment options and cannot join a clinical trial. Th…
Matched conditions: STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE(SR-AGVHD)
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC